2,6-Pyridinedicarboxylicacid, 4-[[(1-carboxy-4-hydroxybutyl)imino]ethylidene]-1,2,3,4-tetrahydro- (9CI) (111534-70-4)

Identification
Name:	2,6-Pyridinedicarboxylicacid, 4-[[(1-carboxy-4-hydroxybutyl)imino]ethylidene]-1,2,3,4-tetrahydro- (9CI)
Synonyms:	5-Hydroxynorvaline-betalamicacid immonium conjugate; Humilixanthin
CAS:	111534-70-4
Molecular Formula:	C14H18 N2 O7
Molecular Weight:	0
InChI:	InChI=1/C14H18N2O7/c17-5-1-2-9(12(18)19)15-4-3-8-6-10(13(20)21)16-11(7-8)14(22)23/h3-4,6,9,11,15,17H,1-2,5,7H2,(H,18,19)(H,20,21)(H,22,23)/b4-3+/t9-,11+/m0/s1
Molecular Structure:
Properties
Flash Point:	365.2°C
Boiling Point:	680.2°C at 760 mmHg
Density:	1.48g/cm³
Refractive index:	1.613
Flash Point:	365.2°C
Safety Data

Other Product

1,2,3,4-Tetrahydro-4-[2-[[1-carboxy-3-(methylsulfinyl)propyl]imino]ethylidene]pyridine-2,6-dicarboxylic acid
2,6-Pyridinedicarboxylicacid, 4-[2-[[(1S)-1,3-dicarboxypropyl]imino]ethylidene]-1,2,3,4-tetrahydro-,(2S,4E)-
(2S)-4-[(1E,2E)-2-[[(S)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethyl]imino]ethylidene]-1,2,3,4-tetrahydro-2,6-pyridinedicarboxylic acid
Glycine,S-[(1R,2Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]-2-pentadecenyl]-L-cysteinyl- (9CI)
1,2,3,4-Tetrahydro-4-[2-(1-carboxy-3-carbamoylpropylimino)ethylidene]-2,6-pyridinedicarboxylic acid
2,6-Pyridinedicarboxylicacid,4-[2-[2-carboxy-2,3-dihydro-5-hydroxy-6-[[6-O-[3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl]-b-D-glucopyranosyl]oxy]-1H-indol-1-yl]ethenyl]-2,3-dihydro-(9CI)
2,6-Pyridinedicarboxylicacid, 4-[2-[2-carboxy-5-(b-D-glucopyranosyloxy)-2,3-dihydro-6-hydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-,monohydrochloride, [S-(R*,R*)]- (9CI)
2,6-Pyridinedicarboxylicacid, 4-[2-[(2S,4R)-2-carboxy-4-hydroxy-1-pyrrolidinyl]ethenyl]-2,3-dihydro-,(2S)-
Glycine,N-[S-[1-(4-carboxy-1-hydroxybutyl)-2-pentadecenyl]-N-L-g-glutamyl-L-cysteinyl]-,[R-[R*,S*-(Z)]]- (9CI)
2,4-Pyridinedicarboxylicacid, 5-(4-carboxy-1,3-cyclopentadien-1-yl)-
2,6-Pyridinedicarboxylicacid,4-[2-[(2S)-2-carboxy-2,3-dihydro-5-hydroxy-6-[[6-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]-b-D-glucopyranosyl]oxy]-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2S)-
2,6-Pyridinedicarboxylicacid,4-[2-[(2S)-2-carboxy-2,3-dihydro-5-hydroxy-6-[[6-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]-b-D-glucopyranosyl]oxy]-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2R)-
2,6-Pyridinedicarboxylicacid,4-[2-[(2S)-2-carboxy-2,3-dihydro-6-hydroxy-5-[[6-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]-b-D-glucopyranosyl]oxy]-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2S)-
4-nitrophenyl (1,3-benzodioxol-5-ylmethyl){10-(3-formylphenoxy)-1,2-bis(4-hydroxybutyl)-6a-(prop-2-en-1-yloxy)-4-[(tetrahydro-2H-pyran-2-yloxy)imino]-1,2,4,5,6,6a,11b,11c-octahydrobenzo[kl]xanthen-6-yl}carbamate
N-(1,3-benzodioxol-5-ylmethyl)-N-{10-(3-formyl-4-methoxyphenoxy)-1,2-bis(4-hydroxybutyl)-6a-(prop-2-en-1-yloxy)-4-[(tetrahydro-2H-pyran-2-yloxy)imino]-1,2,4,5,6,6a,11b,11c-octahydrobenzo[kl]xanthen-6-yl}dodecanamide
1-{6a,10-dihydroxy-1,2-bis(4-hydroxybutyl)-4-[(tetrahydro-2H-pyran-2-yloxy)imino]-1,2,4,5,6,6a,11b,11c-octahydrobenzo[kl]xanthen-6-yl}-3-(1H-indol-2-ylmethyl)-1-propylurea
2,6-Pyridinedicarboxylicacid, 4-[2-[(2S)-2-carboxy-5-[[6-O-(2-carboxyacetyl)-b-D-glucopyranosyl]oxy]-2,3-dihydro-6-hydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2R)-
2-{[2-({1-carboxy-4-[(diaminomethylidene)amino]-3-hydroxybutyl}amino)ethyl]amino}butanedioic acid (non-preferred name)
2,6-Pyridinedicarboxylicacid,4-[2-[(2S)-2-carboxy-2,3-dihydro-5-hydroxy-6-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-b-D-glucopyranosyl]oxy]-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2R)-
2,6-Pyridinedicarboxylicacid, 4-[2-[(2S)-2-carboxy-5-[[6-O-(carboxyacetyl)-b-D-glucopyranosyl]oxy]-2,3-dihydro-6-hydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2S)-